UnitedHealth Group Inc

UnitedHealth Group operates through two massive divisions: UnitedHealthcare, which provides health insurance to 53+ million Americans through employer plans, Medicare Advantage, Medicaid, and individual coverage; and Optum, which delivers pharmacy benefits (OptumRx), data analytics, and direct healthcare services through employed physicians and surgery centers. Optum has become a healthcare technology and services powerhouse, managing pharmacy spending, operating care delivery networks, and providing revenue cycle management software to hospitals—creating a vertically integrated healthcare ecosystem that generates revenue from both insurance premiums and healthcare delivery.

UnitedHealth has delivered consistent double-digit earnings growth by gaining Medicare Advantage enrollment and expanding Optum's higher-margin technology and care delivery businesses. The company benefits from aging demographics driving Medicare growth and healthcare system inefficiencies that Optum can address through data analytics and coordinated care. Risks include regulatory scrutiny of pharmacy benefit managers, potential Medicare Advantage rate pressure, and political debates over healthcare costs. UNH trades at a premium P/E versus health insurers but has historically justified this through superior execution.

In health insurance, UnitedHealth competes with Elevance Health (Anthem), CVS Health (Aetna), Cigna, and Humana in Medicare Advantage. Optum's pharmacy benefits business battles CVS Caremark and Express Scripts (Cigna). In healthcare services, Optum faces physician groups owned by CVS and emerging value-based care companies like Oak Street Health. UnitedHealth's scale and vertical integration make it difficult for competitors to match its data insights and cost management capabilities.

UnitedHealth has raised its dividend for 14 consecutive years, currently yielding about 1.3%. The company follows a balanced capital allocation strategy—returning roughly 25-30% of earnings through dividends while reinvesting heavily in Optum acquisitions and technology infrastructure. Dividend growth has averaged high-single to low-double digits annually, supported by strong free cash flow generation. UNH also repurchases shares opportunistically, making total shareholder returns significantly higher than the dividend yield alone.

UNH last closed at $272.28, up 1.02% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $234.60 and a high of $606.36. The current price represents 10% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.

Among 34 analysts covering UNH, the consensus rating is Buy — 23 rate it a buy, 9 hold, and 2 sell. The average price target sits at $293.85, implying 8% upside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.

UnitedHealth Group Inc generated $443.75B in revenue during fiscal year 2026, with $11.95B reaching the bottom line as net income. The net profit margin of 2.7% reflects the competitive nature of its industry.

UNH trades at a P/E ratio of 21.66 on trailing earnings of $13.19 per share. That's roughly in line with the broader market average of ~20-25x. Comparing this multiple against Health Care sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.

Performance varies across timeframes, reflecting shifting market conditions. Returns by timeframe: -16.88% (3M), -21.21% (6M), -47.28% (1Y), -19.06% (YTD). Comparing these figures against the S&P 500 and sector benchmarks helps determine whether UNH is outperforming or lagging the broader market.